9 Best Small-Cap Growth Stocks to Invest In Now
In this article, we will look at the 9 Best Small-Cap Growth Stocks to Invest In Now.
Vanda Pharmaceuticals Inc. (VNDA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AQR Capital Management Cliff Asness | 3,497,695 | $21,405,893 | +119% | 0.01% |
| 2. | Renaissance Technologies Jim Simons | 3,441,361 | $21,061,129 | -9% | 0.03% |
| 3. | AIGH Investment Partners Orin Hirschman | 2,044,169 | $12,510,315 | -26% | 0.79% |
| 4. | Millennium Management Israel Englander | 1,602,813 | $9,809,216 | -15% | 0% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,225,996 | $7,503,094 | +106% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.15 | 10,000 | $41,500.00 | 2,335,731 | 2025-08-07 | Filing | |
| $4.39 | 481 | $2,111.59 | 2,325,731 | 2025-05-21 | Filing | |
| $4.40 | 9,519 | $41,883.60 | 2,325,250 | 2025-05-21 | Filing | |
| $4.22 | 20,000 | $84,472.00 | 2,315,731 | 2025-05-16 | Filing | |
| $5.01 | 5,000 | $25,050.00 | 2,295,731 | 2025-03-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.27 | 42,434 | $350,755.20 | 377,450 | 2026-03-02 | Filing | |
| $8.27 | 42,442 | $350,821.33 | 411,380 | 2026-03-02 | Filing | |
| $8.27 | 30,800 | $254,589.72 | 333,469 | 2026-03-02 | Filing | |
| $8.17 | 156,235 | $1,276,971.15 | 2,704,496 | 2026-03-02 | Filing | |
| $8.27 | 42,431 | $350,730.40 | 494,197 | 2026-03-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,653,737 | $46,840,870 | 0% | |
| 2. | 3,516,405 | $21,520,399 | 0% | |
| 3. | 2,524,040 | $15,447,125 | 0% | |
| 4. | 1,727,349 | $10,572,544 | 0% | |
| 5. | 1,483,787 | $9,082,993 | 0% |
News See All
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2026 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2026 Earnings Call Transcript May 6, 2026Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.82 EPS, expectations were $-0.688.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2025 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2025 Earnings Call Transcript February 11, 2026Vanda Pharmaceuticals Inc. misses on earnings expectations.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2025 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2025 Earnings Call Transcript October 29, 2025Vanda Pharmaceuticals Inc. misses on earnings expectations.
22 Stocks on Jim Cramer’s Radar Recently
On Friday’s episode of Mad Money, host Jim Cramer commented on the ongoing imbalance between supply and demand and how it is playing out in the market.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2025 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2025 Earnings Call Transcript July 31, 2025Vanda Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.46 EPS, expectations were $-0.34.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2025 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2025 Earnings Call Transcript May 7, 2025Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.55.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2024 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2024 Earnings Call Transcript February 13, 2025Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.08, expectations were $-0.14.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2024 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q3 2024 Earnings Call Transcript November 6, 2024Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.09, expectations were $-0.17.
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2024 Earnings Call Transcript
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q2 2024 Earnings Call Transcript August 2, 2024 Operator: Thank you for standing by. My name is Meg, and I will be your conference operator today.
Hedge Fund Resource Center